Institutional Clinical Trial Accrual Volume and Survival of Patients With Head and Neck Cancer

2014245 citationsJournal Articlebronze Open Access

Authors

Evan Wuthrick · The University of Texas MD Anderson Cancer Center

Qiang Zhang · The University of Texas MD Anderson Cancer Center

Mitchell Machtay · The University of Texas MD Anderson Cancer Center

David I. Rosenthal · The University of Texas MD Anderson Cancer Center

Phuc Félix Nguyen‐Tan · The University of Texas MD Anderson Cancer Center

A. Fortin · The University of Texas MD Anderson Cancer Center

Abstract

OS is worse for patients with HNC treated at HLACs versus HHACs to cooperative group trials after accounting for radiotherapy protocol deviations. Institutional experience substantially influences survival in locally advanced HNC.

Topics & Keywords

Head and Neck Cancer Studies Global Cancer Incidence and Screening Economic and Financial Impacts of Cancer

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 33, Issue 2, pp. 156-164

DOI: 10.1200/jco.2014.56.5218

Field-Weighted Citation Impact: 17.42